Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06430164 · ClinicalTrials.gov registry record · NA

AB Gait Estim Neurophysiology

A NA study of Gait, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06430164: Recruiting NA study of Gait, sponsored by Emory University.

NCT06430164 is a NA study of Gait that is actively recruiting participants, run by Emory University. The registered enrollment target is 50 participants, above the 34-participant average among 5 other Gait trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06430164, a NA study of Gait, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is being done to answer the question: What are the effects of electrical stimulation and stepping practice on connections between the brain and muscles? The long-term goal of this project is to develop novel, effective, and personalized rehabilitation protocols founded on an understanding of neurobiological mechanisms that combine electrical stimulation with gait training to improve gait performance in older adults and stroke survivors. The rationale of this project is to explore and generate preliminary data regarding how electrical stimulation-based strategies modulate cortical and spinal circuits in able-bodied individuals. The researchers will evaluate the effects of short treadmill walking bouts or single gait training sessions with and without electrical stimulation on somatosensory, spinal-reflex, corticospinal circuit neurophysiology, and/or gait performance. The study will provide important preliminary and normative data that can explain how brain circuits change with stimulation or stepping practice and inform future rehabilitation studies on patients. The study population is able-bodied individuals.

Primary Outcome

Marker data will be collected using a 7-camera motion analysis system at 120 Hz (Vicon, Oxford, UK). During treadmill walking, ground reaction forces during the treadmill walking will be collected using a treadmill instrumented with two 6-component force platforms under each belt (Bertec, USA). Ground reaction forces will be evaluated using a force plate embedded within the lab floor (AMTI, USA).

Conditions Studied

Interventions

  • OTHER Gait Training
  • DEVICE Functional electrical stimulation (FES)
  • DEVICE Peripheral electrical stimulation paired with cortical magnetic stimulation pulses

Study Locations (1)

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-02-12
Est. Completion 2026-12
Phase NA
Emory University

1,208 total trials

What NCT06430164 shows while recruiting

NCT06430164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 34-participant average among 5 other Gait trials with a reported enrollment target (47% higher).

The record links to 1 condition, with Gait appearing as the primary indexed condition, and to 3 interventions - of which Gait Training is the first listed.

NCT06430164 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06430164 about?

NCT06430164 is a clinical study titled "AB Gait Estim Neurophysiology". This study is being done to answer the question: What are the effects of electrical stimulation and stepping practice on connections between the brain and muscles? The long-term goal of this project is to develop novel, effective, and personalized rehabilitation protocols founded on an understanding...

What is the current status of trial NCT06430164?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-02-12. Estimated completion is 2026-12.

What conditions does trial NCT06430164 study?

This clinical trial studies the following conditions: Gait.

What interventions are being tested in trial NCT06430164?

The interventions under investigation include: Gait Training (OTHER), Functional electrical stimulation (FES) (DEVICE), Peripheral electrical stimulation paired with cortical magnetic stimulation pulses (DEVICE).

Who is sponsoring clinical trial NCT06430164?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06430164 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gait

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06430164, the US trial registry maintained by the National Library of Medicine. NCT06430164 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.